Study of TENEX Device for Treating Greater Trochanteric Pain Syndrome in Adults Aged 30 to 90
Led by Montefiore Medical Center · Updated on 2026-05-08
150
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the use of an ultrasound-guided percutaneous procedure called TENEX to help people with chronic hip pain caused by Greater Trochanteric Pain Syndrome GTPS. This condition involves repetitive overload of tendons around the hip, leading to pain and mobility issues. The study aims to assess how TENEX affects pain levels and function compared to standard care, especially in patients who have not improved after conservative treatments. The trial is a randomized clinical study sponsored by Montefiore Medical Center.
The study compares two groups one receiving standard care and the other treated with the TENEX device, which partially releases the gluteus medius, minimus, and iliotibial band tendons using ultrasound guidance. The procedure is outpatient and aims to reduce pain and improve mobility in people with refractory GTPS. The treatment effects will be measured at multiple time points, including before treatment and up to two years after.
Participants will be assessed on pain levels using patient-reported outcome measures at baseline and several follow-up visits up to two years. Quality of life will also be evaluated using a standardized questionnaire. Researchers will monitor medication use, walking, standing, and side-lying tolerance to understand functional improvements. The study includes adults aged 30 to 90 who have failed at least six months of conservative medical management, and excludes those with significant mobility restrictions, pregnancy, or prior relevant surgeries.
CONDITIONS
Brief Title
Evaluation of TENEX for Greater Trochanteric Pain Syndrome (GTPS)
Research Team
T
Tahereh Naeimi, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
TENEX device
No intervention control
Conservative care
What it is
An investigational percutaneous device procedure using TENEX to section gluteus medius and iliotibial band tendons
Control group with no procedural intervention
Structured conservative care including physical therapy, activity modification and non‑operative management
Role in trial
Investigational treatment arm
Comparator arm with no intervention
Represents common non‑operative approach for GTPS after failed initial conservative therapy
Primary use
To relieve pain and improve function in patients with GTPS who have failed conservative treatment
Observation without procedural treatment
Manage symptoms and function using physical therapy and non‑operative measures
How it is given or performed
Percutaneous ultrasound‑guided tenotomy using TENEX device
No procedure administered
Physiotherapist‑led exercises, activity modification, NSAIDs and optional injections per care guidelines
Evidence status
Efficacy and durability under investigation in this trial; prior observational percutaneous tenotomy shows durability at one year
No efficacy data; control condition defines natural course without procedural treatment
Conservative treatments like physical therapy and corticosteroid injections provide symptom relief, especially short term via injection and long‑term with physiotherapy
Important risks
No specific safety data available yet
No procedural risks associated
Risks include injection‑related pain and side effects from NSAIDs
Important limitations
Procedure is investigational; limited prior evidence beyond observational studies
No intervention may not reflect usual care expectations for patients failing prior therapy
Corticosteroid injection benefits may be short term and variable
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 30Years - 90Years
All Genders
Eligibility Criteria
You may qualify if you...
Aged 18 to 90 years
Diagnosis of Greater Trochanteric Pain Syndrome confirmed by MRI or CT scan
Ability to independently provide informed consent
Failed conservative medical treatment for at least 6 months
You will not qualify if you...
Significant mobility restrictions or use of a wheelchair
Pregnancy
Previous surgery on the gluteus medius or iliotibial band tendons
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Implementation
Duration - Single procedure visit
Participants receive treatment using the TENEX device for sectioning of the gluteus medius and iliotibial band tendons or standard of care based on random assignment.
1 treatment visit (in-person)
Post-treatment Follow-up
Duration - Up to 2 years
Participants are monitored for pain levels and quality of life after treatment to assess the effectiveness of the TENEX device or standard care.
Visits at 1 month, 3 months, 6 months, 1 year, and 2 years (in-person or remote)
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Comparing Extracorporeal Shockwave Therapy and Standard Physical Therapy
for Adults With Greater Trochanteric Pain Syndrome
Study of TENEX Device for Treating Greater Trochanteric Pain Syndrome in Adults Aged 30 to 90
12-Week Physiotherapist-Led Exercise and Education Program for Adults With Hip Abductor Tendon Pathology and Long-Term Lateral Hip Pain
Evaluating High-Intensity Laser Therapy and Exercise for Adults with Greater Trochanteric Pain Syndrome
ReneuRx Nerve Selective Therapy Compared to Corticosteroid Injection for Lateral Hip Pain A Multi-Center Randomized Controlled Trial
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Percutaneous Ultrasound-Guided Tenotomy of the Iliotibial Band for Trochanteric Pain Syndrome: A Longitudinal Observational Study With One-Year Durability Results.
Exercise and load modification versus corticosteroid injection versus 'wait and see' for persistent gluteus medius/minimus tendinopathy (the LEAP trial): a protocol for a randomised clinical trial.
Rebecca Mellor, Alison Grimaldi, Henry Wajswelner...